Yale Expert Speaks on Metastatic Breast Cancer Awareness Day

Lajos Pusztai, MD, DPhil, Professor of Medicine (Medical Oncology), Chief of Breast Medical Oncology, Smilow Cancer Hospital

He is available at [email protected] or at 203.737.8309

Dr Pusztai is Professor of Medicine at Yale University and Chief of the Breast Medical Oncology Section at the Yale Cancer Center (http://medicine.yale.edu/lab/pusztai/people/ ) . He is also Co-Director of the Cancer Center Genomics, Genetics, and Epigenetics Program. Dr. Pusztai received his medical degree from the Semmelweis University of Medicine in Budapest, and his D.Phil. degree from the University of Oxford in England. His research group has made important contributions to establish that estrogen receptor-positive and-negative breast cancers have fundamentally different molecular, clinical and epidemiological characteristics. He has been a pioneer in evaluating gene expression profiling as a diagnostic technology to predict chemotherapy and endocrine therapy sensitivity and have shown that different biological processes are involved in determining the prognosis and treatment response in different breast cancer subtypes. His group has also developed new bioinformatics tools to integrate information from across different data platforms in order to define the molecular pathways that are disturbed in individual cancers and could provide the bases for individualized treatment strategies.